Pharmaceutical company promises 1, 500 new jobs for Georgia – CBS46 News #pharma #recruitment #agencies

Posted On Apr 26 2017 by

#pharmaceutical company jobs # Pharmaceutical company promises 1,500 new jobs for Georgia It s lunchtime at the Blue Willow Inn and business is booming. It hasn t always been this good. The restaurant fell into bankruptcy three years ago. But better times soon could be ahead when a pharmaceutical company opens up a manufacturing plant a few miles away which could bring in more than 1,500 new workers. Billie Van Dyke, who owns Blue Willow, hopes she gets her slice of the economic pie when Baxter International moves in. “That means my business is going to increase also,” Van Dyke …


Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout #enobia #pharma

Posted On Apr 26 2017 by

#onyx pharma # Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout SOUTH SAN FRANCISCO, Calif. ( TheStreet ) — Every biotech CEO wants to say they bought an asset for X and sold it for 10X, yet few top executives manage to create value on this mammoth scale. Onyx Pharmaceuticals’ ( ONXX ) CEO Tony Coles just did it. The 10X is Amgen ( AMGN ) paying $10 billion in cash ($125 per share) to acquire Onyx. The deal, much discussed and analyzed since June, was finally announced Sunday night. But Amgen wouldn’t be buying Onyx …


Drug company R – D: Nowhere near $1 billion #taro #pharma

Posted On Apr 21 2017 by

#drug research companies # Drug company R D argument for half a century, but the specific source of the $1 billion claim is a 2003 study published in the Journal of Health Economics by economists Joseph DiMasi of Tufts, Ronald W. Hansen of the University of Rochester, and Henry Grabowski of Duke. I will henceforth refer to this team as the Tufts Center group, because they were working out of the (drug-company-funded ) Tufts Center for the Study of Drug Development. The Tufts Center group “obtained from a survey of 10 pharmaceutical firms” the research and development costs of 68 …


Health News, Page 1 – Pharmaceutical Technology #trends #in #pharmaceutical #industry

Posted On Apr 12 2017 by

#pharmaceutical companies news # Health – Page 1 Stay up to date with the latest Health updates from the global pharmaceutical industry Latest Health Update Johns Hopkins Medicine opens new Zika virus treatment and research centre 26 August, 2016 Johns Hopkins Medicine has opened a new centre to provide comprehensive care to patients infected with the Zika. read more Aldevron completes production of Malaria DNA vaccine for US NMRC Wednesday, August 17, 2016 US biomedical manufacturer Aldevron has completed the production and delivery of a DNA-based vaccine to combat malaria for the Naval Medical Research Center. First dengue immunisation public …


Clinical News News, Page 1 – Pharmaceutical Technology #pharmaceutical #rep

Posted On Apr 12 2017 by

#pharmaceutical companies news # Clinical News – Page 1 Stay up to date with the latest Clinical News updates from the global pharmaceutical industry Latest Clinical News Update Pfizer, DCRI and partners collaborate to improve adult vaccination rates 02 September, 2016 Pfizer, Duke Clinical Research Institute (DCRI), Duke Primary Care, and Premier have collaborated to work together to improve adult vaccination rates within a primary care. read more Sunovion to acquire Canada’s Cynapsus Therapeutics for $624m Friday, September 02, 2016 Sunovion Pharmaceuticals has signed an agreement to acquire Canadian-based Cynapsus Therapeutics for. New report says age and general wellbeing can …


Global pharma sales to reach $1 #large #pharmaceutical #companies

Posted On Apr 11 2017 by

#pharmaceutical market size # Global pharma sales to reach $1.3 trillion The 2015 CMR Pharmaceutical R D Factbook reveals a surge in global sales – reaching a milestone of $1 trillion in 2014 – and forecasts continued growth with the expectation of sales reaching $1.3 trillion by 2018. The pharmaceutical market is not in an “Era of Scarcity” as some analysts describe the Pharma R D environment post-2005. Industry data challenges negative perceptions and demonstrates the pharma industry’s continued commitment to creating and employing innovative solutions to tackle its largest hurdles. Key highlights from the 2015 Factbook include: Diversification is …


Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout #mayne #pharma

Posted On Apr 8 2017 by

#onyx pharma # Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout SOUTH SAN FRANCISCO, Calif. ( TheStreet ) — Every biotech CEO wants to say they bought an asset for X and sold it for 10X, yet few top executives manage to create value on this mammoth scale. Onyx Pharmaceuticals’ ( ONXX ) CEO Tony Coles just did it. The 10X is Amgen ( AMGN ) paying $10 billion in cash ($125 per share) to acquire Onyx. The deal, much discussed and analyzed since June, was finally announced Sunday night. But Amgen wouldn’t be buying Onyx …


Companies and Markets News, Page 1 – Pharmaceutical Technology #jamjoom #pharma

Posted On Apr 5 2017 by

#pharmaceutical companies news # Companies and Markets – Page 1 Stay up to date with the latest Companies and Markets updates from the global pharmaceutical industry Latest Companies and Markets Update M read more Deals this week: Elite Pharmaceuticals, Orexigen Therapeutics, LegoChem Biosciences Friday, September 02, 2016 Elite Pharmaceuticals and SunGen Pharma LLC have entered a development and licensing agreement for four generic pharmaceutical. Report: Global diabetes and obesity therapeutics market to double by 2022 Friday, September 02, 2016 The global market for diabetes mellitus and obesity is forecast to increase from $70.8bn in 2015 to $163.2bn by 2022, according …


Legal and Regulatory News, Page 1 – Pharmaceutical Technology #pharmaceutical #suppliers

Posted On Apr 5 2017 by

#pharmaceutical companies news # Legal and Regulatory – Page 1 Stay up to date with the latest Legal and Regulatory updates from the global pharmaceutical industry Latest Legal and Regulatory Update US FDA approves Genmab’s ofatumumab for relapsed CLL 01 September, 2016 Danish biotechnology company Genmab has received the US Food and Drug Administration (FDA) approval for ofatumumab (Arzerra) in combination with fludarabine and cyclophosphamide (FC) to. read more RedHill Biopharma’s RHB-104 receives EU patent for multiple sclerosis treatment Wednesday, August 31, 2016 The European Patent Office (EPO) has issued a European patent covering the use of RedHill Biopharma’s RHB-104 …


Notification to Pharmaceutical Companies: Acceptance of third-party data integrity audit for Cetero studies conducted from March 1, 2008 to August 31, 2009 #new #pharmaceutical #companies

Posted On Apr 2 2017 by

#pharmaceutical companies in houston tx # Notification to Pharmaceutical Companies: Acceptance of third-party data integrity audit for Cetero studies conducted from March 1, 2008 to August 31, 2009 On July 26, 2011 FDA notified pharmaceutical companies that bioanalytical studies conducted at Cetero between April 2005 and June 2010 in support of marketing applications may need to be repeated or confirmed. FDA took this action as a result of two inspections of Cetero s bioanalytical facility in Houston, Texas conducted in 2010, as well as the company s own investigation and third party audit. The inspections and audit identified significant instances …